Long-term survival of women with epithelial ovarian cancer detected by ultrasonographic screening

Obstetrics and Gynecology

Volumn 118, Issue 6, 2011, Pages 1212-1221

  Van Nagell Jr , John Rensselaer ^a,b   Miller, Rachel Ware ^a,b   Desimone, Christopher P ^a,b   Ueland, Frederick R ^a,b   Podzielinski, Iwona ^a,b   Goodrich, Scott T ^a,b   Elder, Jeff W ^a,b   Huang, Bin ^a,b   Kryscio, Richard J ^a,b   Pavlik, Edward John ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CONTROLLED STUDY; EPITHELIAL OVARY CANCER; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; OVARY TUMOR; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; TRANSVAGINAL ECHOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; KENTUCKY; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; OVARY; SURVIVAL RATE;

EID: 81855216360     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e318238d030     Document Type: Article

References (24)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics. 2010. CA Cancer J Clin 2011;61:133-4.
2. Goff BA, Mandel LS, Melancen CH, Munz HG. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA 2004;291:2705-12. (Pubitemid 38725419)
3. Goff BA, Mandel LS, Drescher CW, Urban N, Gough S, Schurman KM, et al. Development of an ovarian cancer symptom index. Cancer 2007;109:221-7.
4. Jelovac D, Armstrong DK. Recent progress in the diagnosis and treatment of ovarian cancer. CA Cancer J Clin 2011;61: 183-203.
5. van Nagell JR, Higgins RV, Donaldson ES, Gallion HH, Powell DE, Pavlik EJ, et al. Transvaginal sonography as a screening method for ovarian cancer. A report of the first 1000 cases screened. Cancer 1990;65:573-7. (Pubitemid 20058377)
6. van Nagell JR, DePriest PD, Ueland FR, DeSimone CP, Cooper AL, Pavlik EJ, et al. Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened. Cancer 2007;109:1887-96. (Pubitemid 46668555)
7. Pavlik EJ, DePriest PD, Gallion HH, Ueland FR, Reedy MB, Kryscio RJ, et al. Ovarian volume related to age. Gynecol Oncol 2000;77:410-2. (Pubitemid 30368559)
8. Ueland F, DePriest P, Pavlik E, Kryscio R, van Nagell JR. Preoperative differentiation of malignant from benign ovarian tumors: the efficacy of morphology indexing and Doppler flow sonography. Gynecol Oncol 2003;91:46-50. (Pubitemid 37188592)
9. Kurman RJ, Shih IeM. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 2010;34:433-43.
10. Jacobs I, Skates SJ, MacDonald N, Menon U, Rosenthal A, Prys Davies A. Outcome of a pilot randomised controlled trial of ovarian cancer screening. Lancet 1999;253:1207-10. (Pubitemid 29168457)
11. Sato S, Yokoyama Y, Sakamoto T, Futagami M, Saito Y. Usefulness of mass screening for ovarian carcinoma using transvaginal ultrasonography. Cancer 2000;89:582-8. (Pubitemid 30640104)
12. Buys S, Partridge E, Greene MH, Prorok PC, Reding D, Riley TL, et al. Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial. Am J Obstet Gynecol 2005;193:1630-9. (Pubitemid 41540458)
13. Partridge E, Kreimer AR, Greenlee RT, Williams C, Xu JL, Church TR, et al. Results from four rounds of ovarian cancer screening in a randomized trial. Obstet Gynecol 2009;113: 775-82.
14. Buys S, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, et al. Effect of screening on ovarian cancer mortality. The Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA 2011;305:2295-303.
15. Havrilesky LJ, Sanders GD, Kulasingam S, Chino JP, Berchuck A, Marks JR, et al. Development of an ovarian cancer screening decision model that incorporates disease heterogeneity: implications for potential mortality reduction. Cancer 2011; 117:545-53.
16. Prorok PC. Evaluation of screening program for the early detection of cancer. Natl Cancer Inst Stat Textbk Monogr 1984;51:267-328.
17. Ueland FR, DePriest P, DeSimone C, Pavlik EJ, Kryscio RJ, van Nagell JR Jr. The accuracy of examination under anesthesia and transvaginal sonography in evaluating ovarian size. Gynecol Oncol 2005;99:400-3. (Pubitemid 41502851)
18. Kosary CL. Cancers of the ovary. SEER survival monograph: cancer survival among adults: US SEER program 1988-2001. National Institutes of Health Publication 7-6215. Bethesda (MD): National Institutes of Health; 2007. p. 133-44.
19. Yancik R. Ovarian cancer. Age contrasts in incidence, histology disease stage at diagnosis, mortality. Cancer 1993; 71(suppl):517-23. (Pubitemid 23021245)
20. Quirk JT, Natarajan N, Mettlin CJ. Age-specific ovarian cancer incidence rate patterns in the United States. Gynecol Oncol 2005;99:248-50. (Pubitemid 41354614)
21. Crum CR, Drapkin R, Miron A, Ince T, Muto M, Kindelberger DW, et al. The distal fallopian tube: a new model for pelvic serous carcinogenesis. Curr Opin Obstet Gynecol 2007; 19:3-9. (Pubitemid 46095865)
22. Modesitt SC, Pavlik EJ, Ueland FR, DePriest PD, Kryscio RJ, van Nagell JR Jr. Risk of malignancy in unilocular ovarian cystic tumors less than 10 centimeters in diameter. Obstet Gynecol 2003;102:594-9. (Pubitemid 37311227)
23. Saunders BA, Podzielinski I, Ware R, Goodrich S, DeSimone C, Ueland FR, et al. Risk of malignancy in sonographically confirmed septated cystic ovarian tumors. Gynecol Oncol 2010;118:278-82.
24. Menon U, Gentry-Maharj A, Hallet R, Ryan A, Burnell M, Jacobs I, et al. Sensitivity and specificity of a multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol 2009;10:327-40.